About the organization
Basic details : The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multinational coalition, managed in collaboration with The Synergist. Its goal is to bring together initiatives and best practices that integrate the voice of the patient throughout the lifecycle of medicines development, thereby speeding up the creation and implementation of an effective, globally standardized framework.
PFMD seeks to have a balanced representation of stakeholders to ensure transparency, inclusiveness, and credibility. Stakeholders include patients and patient organizations across diverse areas of health and industry. We also intend to invite regulators, payers and other professional organizations to the global group to ensure diversity of perspectives.
Mission : By partnering with patients to design and develop new solutions, we can co-create methods for them to achieve their health goals.
To pave the path for new innovations in research and lifecycle of medicine development, we intend to improve the patient experience by prioritizing patient preferences and values and creating synergies across interventions which involve the voice of the patient.
We partner WITH patients.
Vision : Transform the way in which we understand, engage, and partner with patients globally in the design and development of research and medicines by focusing on unmet patient needs. We are bringing together and synergizing disparate but complementary efforts that integrate the voice of the PATIENT across the lifecycle of medicine.
Organization primary focus : Driving patient engagement through co-creation, collaboration, culture change and knowledge sharing
Address
Avenue Louise 523, 1050 - Brussels, BE
Contact us for
General partnerships, Good practice sharing, Opportunities for patient engagement collaborations, Speaking opportunities, Would you like to take part in PFMD's work streams? Contact the PFMD team to discuss more.
Organization main contact email
pfmd@thesynergist.org
Phone number
+32 2 613 1637
People
Nicola Bedlington
Secretary General at European Patients' Forum
Brussels, Belgium
Jan Geissler
Co-Founder
Munich, Germany
PFMD / Patvocates / Leukemia Patient Advocates Foundation / EUPATI
Initiatives
Co-creation of the Patient Engagement "Meta-Framework"
Co-creation Working Group 1: Early development & preclinical phases
150+ PE activities to inform PE Quality Guidance's how to modules
Co-creation Working Group 2: Clinical Trials I-III (Clinical Outcomes Assessment)
Co-creation Working Group 3: Regulatory phase
Co-creation Working Group 4: Post-marketing phase
Co-creation Working Group 5: Transversal PLS of clinical trials and publications
Co-creation Working Group 2b: Clinical Trials I-III (Protocol Development)
Events
18
19
PE Open Forum
02
06
ISPOR Europe 2019
15
15
PFMD Board Meeting
25
26
Patient Engagement Open Forum 2020
Resources
Patient Engagement Quality Guidance
27 Mar 2018
Global Patient Engagement Mapping and Networking Tool – Brochure
12 Jan 2018
Global Patient Engagement Mapping and Networking Tool – One Pager
12 Jan 2018
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action - Article
12 Jan 2018
Reputation Management Toolkit
12 Jan 2018
Patient Focused Medicine Development in a nutshell - Video
12 Jan 2018 Article and blog post
Culture and Process Change as a Priority for Patient Engagement in Medicines Development - Article
12 Jan 2018
Collaborative Patient Engagement: Mapping the Global Landscape - White Paper
12 Jan 2018